Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD

Overview of attention for article published in Current Atherosclerosis Reports, May 2019

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 76 Dimensions

Readers on

mendeley: 88 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 1,238 followers.

Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD. #amchelsinki #tutkimus https://t.co/wd0PjgjJuC

Reply Repost Favourite